Your browser doesn't support javascript.
loading
Serum A08 C1q antibodies are associated with disease activity and prognosis in Chinese patients with lupus nephritis.
Pang, Yun; Tan, Ying; Li, Yongzhe; Zhang, Jianchun; Guo, Yongbing; Guo, Zhiling; Zhang, Chengying; Yu, Feng; Zhao, Ming-Hui.
Afiliación
  • Pang Y; Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, PR China.
  • Tan Y; Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, PR China.
  • Li Y; Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College and Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education; Beijing, PR China.
  • Zhang J; Renal Division, Jing Dong Yu Mei Traditional Chinese Medicine and Western Medicine Integrative Kidney Disease Hospital, Hebei, PR China.
  • Guo Y; Department of Nephrology, Anyang District Hospital, Henan, PR China.
  • Guo Z; Department of Nephrology, First Affiliated Hospital of Henan University of Science and Technology, Henan, PR China.
  • Zhang C; Department of Nephrology, Beijing General Hospital of Armed Police Forces, Beijing, PR China.
  • Yu F; Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, PR China; Department of Neph
  • Zhao MH; Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health of China and Key Laboratory of CKD Prevention and Treatment, Ministry of Education of China, Beijing, PR China; Peking-Tsinghua Ce
Kidney Int ; 90(6): 1357-1367, 2016 12.
Article en En | MEDLINE | ID: mdl-27745701
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Complemento C1q Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Kidney Int Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Nefritis Lúpica / Complemento C1q Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: Kidney Int Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos